1. Home
  2. NLSP vs LFLY Comparison

NLSP vs LFLY Comparison

Compare NLSP & LFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • LFLY
  • Stock Information
  • Founded
  • NLSP 2015
  • LFLY 2010
  • Country
  • NLSP Switzerland
  • LFLY United States
  • Employees
  • NLSP N/A
  • LFLY N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • LFLY Computer Software: Prepackaged Software
  • Sector
  • NLSP Health Care
  • LFLY Technology
  • Exchange
  • NLSP Nasdaq
  • LFLY Nasdaq
  • Market Cap
  • NLSP 5.2M
  • LFLY 5.0M
  • IPO Year
  • NLSP 2021
  • LFLY N/A
  • Fundamental
  • Price
  • NLSP $1.94
  • LFLY $1.66
  • Analyst Decision
  • NLSP
  • LFLY Strong Buy
  • Analyst Count
  • NLSP 0
  • LFLY 2
  • Target Price
  • NLSP N/A
  • LFLY $7.59
  • AVG Volume (30 Days)
  • NLSP 535.3K
  • LFLY 43.7K
  • Earning Date
  • NLSP 12-31-2024
  • LFLY 11-07-2024
  • Dividend Yield
  • NLSP N/A
  • LFLY N/A
  • EPS Growth
  • NLSP N/A
  • LFLY N/A
  • EPS
  • NLSP N/A
  • LFLY N/A
  • Revenue
  • NLSP N/A
  • LFLY $35,868,000.00
  • Revenue This Year
  • NLSP N/A
  • LFLY N/A
  • Revenue Next Year
  • NLSP N/A
  • LFLY N/A
  • P/E Ratio
  • NLSP N/A
  • LFLY N/A
  • Revenue Growth
  • NLSP N/A
  • LFLY N/A
  • 52 Week Low
  • NLSP $1.73
  • LFLY $1.10
  • 52 Week High
  • NLSP $24.32
  • LFLY $5.10
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 33.52
  • LFLY 60.15
  • Support Level
  • NLSP $1.78
  • LFLY $1.10
  • Resistance Level
  • NLSP $2.79
  • LFLY $1.76
  • Average True Range (ATR)
  • NLSP 0.33
  • LFLY 0.15
  • MACD
  • NLSP 0.04
  • LFLY 0.04
  • Stochastic Oscillator
  • NLSP 11.77
  • LFLY 78.79

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About LFLY Leafly Holdings Inc.

Leafly Holdings Inc operates an online cannabis information resource platform. It offers cannabis retailers and brands subscription-based marketplace listings that provide its cannabis audience with information, reviews, menus, and ordering and delivery options through legal retailers.

Share on Social Networks: